Article information
Abstract
Over the last 10 years, the advent of evidence-based medicine has caused a paradigm shift in medical thinking and clinical practice. The Cochrane Skin Group organizes, drafts, publishes, and updates systematic reviews of randomized clinical trials of therapeutic interventions in skin diseases to assist in evidence-based clinical decision making. This article provides background information on the history and operation of this group, including the process by which systematic reviews are prepared.
Key words:
Cochrane Collaboration
systematic review
evidence-based dermatology
Resumen
El concepto de medicina basada en la evidencia ha aportado desde la pasada década un nuevo paradigma al pensamiento médico y a la práctica clínica. El Grupo Cochrane de Piel organiza, prepara, disemina y actualiza revisiones sistemáticas de ensayos clínicos aleatorizados sobre intervenciones terapéuticas en Dermatología que proporcionan evidencia científica para informar sobre las decisiones clínicas. Este artículo proporciona la información básica para conocer sus orígenes y funcionamiento, incluido el proceso de elaboración de las revisiones sistemáticas.
Palabras clave:
Colaboración Cochrane
revisión sistemática
Dermatología basada en la evidencia
Full text is only aviable in PDF
References
[1.]
U. González Castro, J. Luelmo Aguilar.
Medicina basada en la evidencia. Por una dermatología clínica más científica.
Arch Dermatol (Ed. Esp.), 10 (1999), pp. 92-93
[2.]
A.L. Cochrane.
Effectiveness and Efficiency: random reflections on health services.
Nuffield Provincial Hospitals Trust, (1972),
[3.]
U. González Castro, J. Luelmo Aguilar, X. Bonfill Cosp.
La Colaboración Cochrane. Perspectivas en dermatología.
Actas Dermosifiliogr, 89 (1998), pp. 206-210
[4.]
A. Collier, L. Heilig, L. Schilling, H. Williams, R.P. Dellavalle.
Cochrane Skin Group systematic reviews are more methodologically rigorous than other systematic reviews in dermatology.
Br J Dermatol, 155 (2006), pp. 1230-1235
[5.]
[cited 2007 April 11] Available from: http://www.cochrane.org
[6.]
[cited 2007 April 11] Available from: http://www.cochrane.es
[7.]
H. Williams, K. Adetugbo, A.L. Po, L. Naldi, T. Diepgen, D. Murrell, The Cochrane Skin Group.
Preparing, maintaining, and disseminating systematic reviews of clinical interventions in dermatology.
Arch Dermatol, 134 (1998), pp. 1620-1626
[8.]
Leonard T, Williams H, Delamere F. Cochrane Skin Group. About the Cochrane Collaboration (Collaborative Review Groups). The Cochrane Library 2007, Issue 1. Art. No.: SKIN.
[9.]
Cochrane Sexually Transmitted Diseases Group. About the Cochrane Collaboration (Collaborative Review Groups). The Cochrane Library 2007, Issue 1. Art. No.: STD.
[10.]
F.M. Delamere, H.C. Williams.
How can hand searching the dermatological literature help people with skin problems?.
Arch Dermatol, 137 (2001), pp. 332-335
[11.]
[cited 2007 May 5] Available from: http://www.nottingham.ac.uk/dermatology/index.php
[12.]
[cited 2007 May 5] Available from: http://www.nottingham.ac.uk/csg
[13.]
A. Collier, K. Johnson, L. Heilig, T. Leonard, H. Williams, R.P. Dellavalle.
A win-win proposition: Fostering US health care consumer involvement in the Cochrane Collaboration Skin Group.
J Am Acad Dermatol, 53 (2005), pp. 920-921
[14.]
M.E. Whitton, D.M. Ashcroft, C.W. Barrett, U. Gonzalez.
Interventions for vitiligo.
Cochrane Database of Systematic Reviews, (2006),
[15.]
H.M. Dobbins, F.M. Delamere, M.J. Sladden, R. Sinclair.
Interventions for alopecia areata.
(Protocol) Cochrane Database of Systematic Reviews, (2003),
[16.]
S. Ladhani.
The need for evidence-based management of skin diseases.
Int J Dermatol, 36 (1997), pp. 17-22
[17.]
H.C. Williams.
Evening primrose oil for atopic dermatitis.
BMJ, 327 (2003), pp. 1358-1359
[18.]
C. Hoare, A. Li Wan Po, H. Williams.
Systematic review of treatments for atopic eczema.
Health Technol Assess, 4 (2000), pp. 1-191
[20.]
C. Sakala.
The Cochrane pregnancy and childbirth database. Implications for perinatal care policy and practice in the United States.
Eval Health Prof, 18 (1995), pp. 428-466
[21.]
Cochrane Injuries Group Albumin Reviewers.
Human albumin administration in critically ill patients: systematic review of randomised controlled trials.
BMJ, 317 (1998), pp. 235-240
[22.]
Eclampsia Trial Collaborative Group.
Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial.
Lancet, 345 (1995), pp. 1455-1463
[23.]
[cited 2007 May 5] Available from: www.update-software.com/Clibplus/clibplus.asp
[24.]
[cited 2007 May 5] Available from: www.cochrane.org/admin/manual.htm
[25.]
[cited 2007 May 5] Available from: www.cc-ims.net/Rev-Man
[26.]
[cited 2007 May 5] Available from: www.cochrane.org/contact/entities.htm#CRGLIST
[27.]
[cited 2007 May 5] Available from: http://www.crd.york.ac.uk/crdweb/
[28.]
M. Bigby.
Evidence-based medicine in a nutshell. A guide to finding and using the best evidence in caring for patients.
Arch Dermatol, 34 (1998), pp. 1609-1618
[29.]
[cited 2007 May 5] Available from: www.nottingham.ac.uk/csg/about/UnpubdTrialsAmnesty.dwt
[30.]
M. Bigby, R.S. Stern, J.A. Bigby.
An evaluation of method reporting and use in clinical trials in dermatology.
Arch Dermatol, 121 (1985), pp. 1394-1399
[31.]
K. Adetugbo, H. Williams.
How well are randomized controlled trials reported in the dermatology literature?.
Arch Dermatol, 136 (2000), pp. 381-385
[32.]
L. Naldi, A. Svensson, T. Diepgen, P. Elsner, J. Grob, P. Coenraads, et al.
European Dermato-Epidemiology Network. Randomized clinical trials for psoriasis 1977-2000: The EDEN survey.
J Invest Dermatol, 120 (2003), pp. 738-741
[33.]
I. Chalmers.
In the dark: Drug companies should be forced to publish all the results of clinical trials.
New Sci, 181 (2004), pp. 19
[34.]
[cited 2007 May 5] Available from: www.centrocochranedobrasil.org.br
Copyright © 2007. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
